The current approval of Takeda’s Takhzyro pre-filled pen is an addition to the existing 150 mg and 300 mg pre-filled syringes ...
BridGene strikes another partnership with Takeda as the latter company continues its dealmaking streak, following high-ticket ...
Takeda has returned to BridGene Biosciences for another small-molecule collaboration—this time focused on immunology as well ...
BridGene Biosciences Inc. has entered a strategic collaboration and licensing agreement with Takeda through which it will use ...
BridGene Biosciences, Inc., a leader in the discovery of small molecule drugs for traditionally "hard-to-drug" targets, announced today a strategic collaboration and licensing agreement with Takeda.
Zurich: Takeda has announced that the European Medicines Agency (EMA) has given approval for an additional 2 mL pre-filled ...
Takeda (TAK) announced that the EMA has approved an additional two mL pre-filled pen option for Takhzyro for subcutaneous administration in ...
Takeda, a global biopharmaceutical company with a manufacturing site in Stanton Springs, unveiled its new Biomedical Waste ...
A Japanese version of the U.S. Esophageal Hypervigilance and Anxiety Scale questionnaire to investigate the psychological ...
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the company has appointed Timothy P. Walbert, former chairman, president and chief executive officer of Horizon Therapeutics, to the ...
The online arm of CSU said it identified the need for the new programs using job demand and wage data, market trends and ...
1 (tie), Lauren Coughlin, Georgia Hall, Minjee Lee, Madelene Sagstrom, Maja Stark and Angel Yin, 2. 7, 33 tied with 1. 1 (tie), Jaravee Boonchant, In Gee Chun, Danielle Kang, Ruixin Liu, Ryann O'Toole ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results